用于外周血干细胞采集的集落刺激因子预处理
Colony-stimulating factor priming for collection of peripheral blood stem cells.
出版信息
Tecnologica. 1995 May:7-8.
PMID:10168290
Abstract
This article is an executive summary of the Blue Cross Blue Shield Technology Evaluation Center (TEC) Assessment "Colony-Stimulating Factor Priming for Collection of Peripheral Blood Stem Cells," Volume 9, No. 21, 1994. The complete assessment, which includes background information, methods, formulation of the assessment, review of evidence, conclusions, and references are available to Blue Cross Blue Shield TEC Program subscribers only. For subscription information, contact the program at (312) 440-6080.
摘要
本文是蓝十字蓝盾技术评估中心（TEC）评估报告《用于外周血干细胞采集的集落刺激因子预处理》的执行摘要，该评估报告于1994年第9卷第21期发布。完整的评估报告包括背景信息、方法、评估报告的制定、证据审查、结论和参考文献，仅提供给蓝十字蓝盾TEC计划的订阅者。如需订阅信息，请致电（312）440-6080联系该计划。
相似文献
1
Colony-stimulating factor priming for collection of peripheral blood stem cells.用于外周血干细胞采集的集落刺激因子预处理
Tecnologica. 1995 May:7-8.
2
3
Intravenous immune globulin for multiple sclerosis.用于治疗多发性硬化症的静脉注射免疫球蛋白
Tecnologica. 1995 May:10.
4
5
6
High-dose chemotherapy with autologous stem-cell support for epithelial ovarian cancer.
Tecnologica MAP Suppl. 1999 Jan:5-7.
7
High-dose chemotherapy with autologous stem-cell support for epithelial ovarian cancer.
Tecnologica MAP Suppl. 1998 Feb:15-7.
8
High-dose chemotherapy with autologous stem-cell support in the treatment of high-risk, primary breast cancer.高剂量化疗联合自体干细胞支持治疗高危原发性乳腺癌。
Tecnologica MAP Suppl. 1999 Jan:8-10.
9
Zotero 插件